{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:17:47Z","timestamp":1790741867620,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"vor","delay-in-days":1328,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Auckland Uniservices","award":["5000293"],"award-info":[{"award-number":["5000293"]}]},{"name":"New Zealand Lottery Health Research","award":["3702828"],"award-info":[{"award-number":["3702828"]}]},{"DOI":"10.13039\/501100001518","name":"Maurice and Phyllis Paykel Trust","doi-asserted-by":"publisher","award":["3708721"],"award-info":[{"award-number":["3708721"]}],"id":[{"id":"10.13039\/501100001518","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001527","name":"New Zealand Optometric Vision Research Foundation","doi-asserted-by":"publisher","award":["3717092"],"award-info":[{"award-number":["3717092"]}],"id":[{"id":"10.13039\/501100001527","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s13311-019-00786-5","type":"journal-article","created":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T20:01:45Z","timestamp":1571688105000},"page":"371-387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Connexin Hemichannel Block Using Orally Delivered Tonabersat Improves Outcomes in Animal Models of Retinal Disease"],"prefix":"10.1016","volume":"17","author":[{"given":"Mohd Nasir","family":"Mat Nor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilva D.","family":"Rupenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin R.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5018-339X","authenticated-orcid":false,"given":"Monica L.","family":"Acosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-019-00786-5_bib1","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fphys.2014.00078","article-title":"Involvement of gap junction channels in the pathophysiology of migraine with aura","volume":"5","author":"Sarrouilhe","year":"2014","journal-title":"Front Physiol."},{"issue":"Suppl 2","key":"10.1007\/s13311-019-00786-5_bib2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1468-2982.2009.01973.x","article-title":"Tonabersat, a novel gap-junction modulator for the prevention of migraine","volume":"29","author":"Silberstein","year":"2009","journal-title":"Cephalalgia."},{"issue":"Suppl 2","key":"10.1007\/s13311-019-00786-5_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1468-2982.2009.01974.x","article-title":"Tonabersat, a gap-junction modulator: efficacy and safety in two randomized, placebo-controlled, dose-ranging studies of acute migraine","volume":"29","author":"Silberstein","year":"2009","journal-title":"Cephalalgia."},{"key":"10.1007\/s13311-019-00786-5_bib4","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S1474-4422(09)70135-8","article-title":"Effects of tonabersat on migraine with aura: a randomised, double-blind, placebo-controlled crossover study","volume":"8","author":"Hauge","year":"2009","journal-title":"The Lancet Neurology."},{"key":"10.1007\/s13311-019-00786-5_bib5","first-page":"1","article-title":"Tonabersat for migraine prophylaxis: a systematic review","volume":"17","author":"Cao","year":"2014","journal-title":"Pain physician."},{"key":"10.1007\/s13311-019-00786-5_bib6","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S1474-4422(09)70174-7","article-title":"Tonabersat for migraine prevention: new life or last gasp?","volume":"8","author":"Dodick","year":"2009","journal-title":"The Lancet Neurology."},{"key":"10.1007\/s13311-019-00786-5_bib7","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0960-894X(98)00728-8","article-title":"Identification of (-)-cis-6-acetyl-4S-(3-chloro-4-fluoro-benzoylamino)- 3,4-dihydro-2,2-dimethyl-2H-benzo [b]pyran-3S-ol as a potential antimigraine agent","volume":"9","author":"Chan","year":"1999","journal-title":"Bioorganic & medicinal chemistry letters."},{"key":"10.1007\/s13311-019-00786-5_bib8","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1038\/sj.bjp.0703932","article-title":"Tonabersat (SB-220453) a novel benzopyran with anticonvulsant properties attenuates trigeminal nerve-induced neurovascular reflexes","volume":"132","author":"Parsons","year":"2001","journal-title":"Br J Pharmacol."},{"key":"10.1007\/s13311-019-00786-5_bib9","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1007\/s13311-017-0536-9","article-title":"Tonabersat Prevents Inflammatory Damage in the Central Nervous System by Blocking Connexin43 Hemichannels","volume":"14","author":"Kim","year":"2017","journal-title":"Neurotherapeutics."},{"key":"10.1007\/s13311-019-00786-5_bib10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/glia.21246","article-title":"Glucose increases intracellular free Ca(2+) in tanycytes via ATP released through connexin 43 hemichannels","volume":"60","author":"Orellana","year":"2012","journal-title":"Glia."},{"key":"10.1007\/s13311-019-00786-5_bib11","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/glia.22785","article-title":"Activated microglia impairs neuroglial interaction by opening Cx43 hemichannels in hippocampal astrocytes","volume":"63","author":"Abudara","year":"2015","journal-title":"Glia."},{"key":"10.1007\/s13311-019-00786-5_bib12","doi-asserted-by":"crossref","first-page":"13781","DOI":"10.1523\/JNEUROSCI.2042-07.2007","article-title":"Cx43 hemichannels and gap junction channels in astrocytes are regulated oppositely by proinflammatory cytokines released from activated microglia","volume":"27","author":"Retamal","year":"2007","journal-title":"J Neurosci."},{"key":"10.1007\/s13311-019-00786-5_bib13","first-page":"385","article-title":"The inflammasome pathway is amplified and perpetuated in an autocrine manner through connexin43 hemichannel mediated ATP release","volume":"2018","author":"Mugisho","year":"1862","journal-title":"Biochim Biophys Acta Gen Subj."},{"key":"10.1007\/s13311-019-00786-5_bib14","first-page":"68","article-title":"Characterizing the mode of action of extracellular Connexin43 channel blocking mimetic peptides in an in vitro ischemia injury model","volume":"2017","author":"Kim","year":"1861","journal-title":"Biochim Biophys Acta Gen Subj."},{"key":"10.1007\/s13311-019-00786-5_bib15","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s13346-015-0249-8","article-title":"Intravitreal injection of lipoamino acid-modified connexin43 mimetic peptide enhances neuroprotection after retinal ischemia","volume":"5","author":"Chen","year":"2015","journal-title":"Drug Deliv Transl Res."},{"key":"10.1007\/s13311-019-00786-5_bib16","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ejpb.2014.12.005","article-title":"Sustained intravitreal delivery of connexin43 mimetic peptide by poly(D,L-lactide-co-glycolide) acid micro- and nanoparticles\u2013Closing the gap in retinal ischaemia","volume":"95","author":"Chen","year":"2015","journal-title":"Eur J Pharm Biopharm."},{"key":"10.1007\/s13311-019-00786-5_bib17","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1167\/iovs.17-22829","article-title":"Sustained Connexin43 Mimetic Peptide Release From Loaded Nanoparticles Reduces Retinal and Choroidal Photodamage","volume":"59","author":"Mat Nor","year":"2018","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"10.1007\/s13311-019-00786-5_bib18","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/brain\/awr338","article-title":"Connexin43 mimetic peptide reduces vascular leak and retinal ganglion cell death following retinal ischaemia","volume":"135","author":"Danesh-Meyer","year":"2012","journal-title":"Brain."},{"key":"10.1007\/s13311-019-00786-5_bib19","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1167\/iovs.15-16643","article-title":"Connexin43 Mimetic Peptide Improves Retinal Function and Reduces Inflammation in a Light-Damaged Albino Rat Model","volume":"57","author":"Guo","year":"2016","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"10.1007\/s13311-019-00786-5_bib20","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00109-018-1727-5","article-title":"Connexin43 hemichannel block protects against the development of diabetic retinopathy signs in a mouse model of the disease","volume":"97","author":"Mugisho","year":"2019","journal-title":"J Mol Med (Berl)."},{"key":"10.1007\/s13311-019-00786-5_bib21","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.biomaterials.2018.03.034","article-title":"Hyaluronic acid coated albumin nanoparticles for targeted peptide delivery in the treatment of retinal ischaemia","volume":"168","author":"Huang","year":"2018","journal-title":"Biomaterials."},{"key":"10.1007\/s13311-019-00786-5_bib22","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00232-012-9460-4","article-title":"Regulation of connexin43 gap junction protein triggers vascular recovery and healing in human ocular persistent epithelial defect wounds","volume":"245","author":"Ormonde","year":"2012","journal-title":"J Membr Biol."},{"key":"10.1007\/s13311-019-00786-5_bib23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.preteyeres.2015.09.004","article-title":"Connexin43 in retinal injury and disease","volume":"51","author":"Danesh-Meyer","year":"2016","journal-title":"Prog Retin Eye Res."},{"key":"10.1007\/s13311-019-00786-5_bib24","doi-asserted-by":"crossref","unstructured":"Mugisho OO, Green CR, Zhang J, Acosta ML, Rupenthal ID. Connexin43 hemichannels: A potential drug target for the treatment of diabetic retinopathy. Drug Discov Today. 2019.","DOI":"10.1016\/j.drudis.2019.01.011"},{"key":"10.1007\/s13311-019-00786-5_bib25","first-page":"670","article-title":"Gap junction proteins in the light-damaged albino rat","volume":"20","author":"Guo","year":"2014","journal-title":"Mol Vis."},{"key":"10.1007\/s13311-019-00786-5_bib26","first-page":"782","article-title":"Extreme retinal remodeling triggered by light damage: implications for age related macular degeneration","volume":"14","author":"Marc","year":"2008","journal-title":"Mol Vis."},{"key":"10.1007\/s13311-019-00786-5_bib27","first-page":"450","article-title":"Retinal damage by light in rats","volume":"5","author":"Noell","year":"1966","journal-title":"Invest Ophthalmol."},{"key":"10.1007\/s13311-019-00786-5_bib28","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/978-3-319-17121-0_12","article-title":"VEGF-A and the NLRP3 Inflammasome in Age-Related Macular Degeneration","volume":"854","author":"Marneros","year":"2016","journal-title":"Adv Exp Med Biol."},{"key":"10.1007\/s13311-019-00786-5_bib29","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1167\/iovs.17-22816","article-title":"Enhanced Expression of NLRP3 Inflammasome-Related Inflammation in Diabetic Retinopathy","volume":"59","author":"Chen","year":"2018","journal-title":"Invest Ophthalmol Vis Sci."},{"issue":"Suppl 2","key":"10.1007\/s13311-019-00786-5_bib30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1468-2982.2009.01975.x","article-title":"Efficacy and safety of tonabersat, a gap-junction modulator, in the acute treatment of migraine: a double-blind, parallel-group, randomized study","volume":"29","author":"Dahlof","year":"2009","journal-title":"Cephalalgia."},{"key":"10.1007\/s13311-019-00786-5_bib31","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1468-2982.2008.01804.x","article-title":"Randomized, double-blind, placebo-controlled, proof-of-concept study of the cortical spreading depression inhibiting agent tonabersat in migraine prophylaxis","volume":"29","author":"Goadsby","year":"2009","journal-title":"Cephalalgia."},{"key":"10.1007\/s13311-019-00786-5_bib32","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1271\/bbb.67.2396","article-title":"Characterization of streptozotocin-induced diabetic rats and pharmacodynamics of insulin formulations","volume":"67","author":"Lee","year":"2003","journal-title":"Biosci Biotechnol Biochem."},{"key":"10.1007\/s13311-019-00786-5_bib33","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1159\/000487029","article-title":"Alpha-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R","volume":"45","author":"Cai","year":"2018","journal-title":"Cell Physiol Biochem."},{"key":"10.1007\/s13311-019-00786-5_bib34","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/cne.22530","article-title":"Characterization of retinal function and glial cell response in a mouse model of oxygen-induced retinopathy","volume":"519","author":"Vessey","year":"2011","journal-title":"J Comp Neurol."},{"key":"10.1007\/s13311-019-00786-5_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2007.09.003","article-title":"Rodent electroretinography: methods for extraction and interpretation of rod and cone responses","volume":"27","author":"Weymouth","year":"2008","journal-title":"Prog Retin Eye Res."},{"key":"10.1007\/s13311-019-00786-5_bib36","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1007\/s00417-008-0895-3","article-title":"Comparison of visual function in pigmented and albino rats by electroretinography and visual evoked potentials","volume":"246","author":"Heiduschka","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"key":"10.1007\/s13311-019-00786-5_bib37","series-title":"Introduction to Epilepsy","first-page":"396","article-title":"Antiepileptic drugs currently under development","author":"Patsalos","year":"2012"},{"key":"10.1007\/s13311-019-00786-5_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2008.09.005","article-title":"Progress report on new antiepileptic drugs: a summary of the Ninth Eilat Conference (EILAT IX)","volume":"83","author":"Bialer","year":"2009","journal-title":"Epilepsy Res."},{"key":"10.1007\/s13311-019-00786-5_bib39","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s00109-015-1275-1","article-title":"Light induces NLRP3 inflammasome activation in retinal pigment epithelial cells via lipofuscin-mediated photooxidative damage","volume":"93","author":"Brandstetter","year":"2015","journal-title":"J Mol Med (Berl)"},{"key":"10.1007\/s13311-019-00786-5_bib40","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/15419060802014164","article-title":"Connexin 43 mimetic peptides reduce swelling, astrogliosis, and neuronal cell death after spinal cord injury","volume":"15","author":"O'Carroll","year":"2008","journal-title":"Cell Commun Adhes."},{"key":"10.1007\/s13311-019-00786-5_bib41","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/(SICI)1096-9861(19970602)382:2<199::AID-CNE5>3.0.CO;2-Z","article-title":"Connexin43 and astrocytic gap junctions in the rat spinal cord after acute compression injury","volume":"382","author":"Theriault","year":"1997","journal-title":"The Journal of comparative neurology."},{"key":"10.1007\/s13311-019-00786-5_bib42","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1089\/neu.2016.4625","article-title":"Systemic Administration of Connexin43 Mimetic Peptide Improves Functional Recovery after Traumatic Spinal Cord Injury in Adult Rats","volume":"34","author":"Mao","year":"2017","journal-title":"J Neurotrauma."},{"key":"10.1007\/s13311-019-00786-5_bib43","first-page":"102","article-title":"Gap junction proteins and their role in spinal cord injury","volume":"7","author":"Tonkin","year":"2014","journal-title":"Frontiers in Molecular Neuroscience."},{"key":"10.1007\/s13311-019-00786-5_bib44","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/s41418-018-0150-3","article-title":"Glucocorticoid receptor in astrocytes regulates midbrain dopamine neurodegeneration through connexin hemichannel activity","volume":"26","author":"Maatouk","year":"2019","journal-title":"Cell Death Differ."},{"key":"10.1007\/s13311-019-00786-5_bib45","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1038\/cdd.2016.63","article-title":"Astroglial connexin43 contributes to neuronal suffering in a mouse model of Alzheimer's disease","volume":"23","author":"Yi","year":"2016","journal-title":"Cell Death Differ."},{"key":"10.1007\/s13311-019-00786-5_bib46","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.22654","article-title":"Connexin hemichannel blockade improves outcomes in a model of fetal ischemia","volume":"71","author":"Davidson","year":"2012","journal-title":"Ann Neurol."},{"key":"10.1007\/s13311-019-00786-5_bib47","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3389\/fphys.2019.00141","article-title":"The Role of Connexin and Pannexin Channels in Perinatal Brain Injury and Inflammation","volume":"10","author":"Zhou","year":"2019","journal-title":"Front Physiol."},{"key":"10.1007\/s13311-019-00786-5_bib48","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/pr.2013.188","article-title":"Astrocytes and microglia in acute cerebral injury underlying cerebral palsy associated with preterm birth","volume":"75","author":"Mallard","year":"2014","journal-title":"Pediatr Res."},{"issue":"Suppl 1","key":"10.1007\/s13311-019-00786-5_bib49","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12860-016-0096-6","article-title":"The absence of dysferlin induces the expression of functional connexin-based hemichannels in human myotubes","volume":"17","author":"Cea","year":"2016","journal-title":"BMC Cell Biol"},{"key":"10.1007\/s13311-019-00786-5_bib50","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1007\/s00018-016-2132-2","article-title":"Fast skeletal myofibers of mdx mouse, model of Duchenne muscular dystrophy, express connexin hemichannels that lead to apoptosis","volume":"73","author":"Cea","year":"2016","journal-title":"Cell Mol Life Sci."},{"key":"10.1007\/s13311-019-00786-5_bib51","doi-asserted-by":"crossref","first-page":"e21108","DOI":"10.1371\/journal.pone.0021108","article-title":"Blockade of gap junction hemichannel suppresses disease progression in mouse models of amyotrophic lateral sclerosis and Alzheimer's disease","volume":"6","author":"Takeuchi","year":"2011","journal-title":"PLoS One."},{"key":"10.1007\/s13311-019-00786-5_bib52","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3389\/fncel.2014.00189","article-title":"Gap junctions and hemichannels composed of connexins: potential therapeutic targets for neurodegenerative diseases","volume":"8","author":"Takeuchi","year":"2014","journal-title":"Front Cell Neurosci."},{"key":"10.1007\/s13311-019-00786-5_bib53","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3389\/fphys.2014.00172","article-title":"Roles of gap junctions, connexins, and pannexins in epilepsy","volume":"5","author":"Mylvaganam","year":"2014","journal-title":"Front Physiol."},{"key":"10.1007\/s13311-019-00786-5_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2017.10.016","article-title":"Attenuation of mechanical pain hypersensitivity by treatment with Peptide5, a connexin-43 mimetic peptide, involves inhibition of NLRP3 inflammasome in nerve-injured mice","volume":"300","author":"Tonkin","year":"2018","journal-title":"Exp Neurol."},{"key":"10.1007\/s13311-019-00786-5_bib55","doi-asserted-by":"crossref","first-page":"e0202156","DOI":"10.1371\/journal.pone.0202156","article-title":"Intravitreal pro-inflammatory cytokines in non-obese diabetic mice: Modelling signs of diabetic retinopathy","volume":"13","author":"Mugisho","year":"2018","journal-title":"PLoS One."},{"key":"10.1007\/s13311-019-00786-5_bib56","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1124\/pr.115.012062","article-title":"Connexins in Cardiovascular and Neurovascular Health and Disease: Pharmacological Implications","volume":"69","author":"Leybaert","year":"2017","journal-title":"Pharmacol Rev."}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-019-00786-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13311-019-00786-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923014034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923014034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-019-00786-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:01:55Z","timestamp":1761807715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923014034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S1878747923014034"],"URL":"https:\/\/doi.org\/10.1007\/s13311-019-00786-5","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Connexin Hemichannel Block Using Orally Delivered Tonabersat Improves Outcomes in Animal Models of Retinal Disease","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-019-00786-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}